Latest Antibody-dependent cell-mediated cytotoxicity Stories
BREDA, The Netherlands and GHENT, Belgium, May 29, 2014 /PRNewswire/ -- arGEN-X will present full results from the dose-escalation part of a Phase 1 study of ARGX-110,
Frozen, Thaw-and-Use Cells Reduce Variability Compared to PBMCs and NK Cells Madison, WI (PRWEB) October 10, 2012 Promega Corporation announces the introduction
PRINCETON, N.J., June 23 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline (GSK).
PRINCETON, N.J. and WALTHAM, Mass., Oct. 21 /PRNewswire/ -- BioWa, Inc. (BioWa) and NKT Therapeutics, Inc.
PRINCETON, N.J., Oct. 5 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into an agreement with Otsuka Pharmaceutical Co. Ltd.
PRINCETON, N.J., July 15 /PRNewswire/ -- BioWa, Inc.
PRINCETON, N.J., Dec.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.